ENO2 and lung carcinoma: However, it has been suggested [10] that the sensitivity and specificity of NSE are inferior to those of pro-gastrin-releasing peptide (ProGRP), indicating that its diagnostic value for pulmonary nodules or lung cancer remains limited.